CA2359486A1 - Polypeptides basb052 de neisseria meningitidis - Google Patents

Polypeptides basb052 de neisseria meningitidis Download PDF

Info

Publication number
CA2359486A1
CA2359486A1 CA002359486A CA2359486A CA2359486A1 CA 2359486 A1 CA2359486 A1 CA 2359486A1 CA 002359486 A CA002359486 A CA 002359486A CA 2359486 A CA2359486 A CA 2359486A CA 2359486 A1 CA2359486 A1 CA 2359486A1
Authority
CA
Canada
Prior art keywords
polypeptide
polynucleotide
seq
sequence
basb052
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002359486A
Other languages
English (en)
Inventor
Jean-Louis Ruelle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9901946.5A external-priority patent/GB9901946D0/en
Application filed by Individual filed Critical Individual
Publication of CA2359486A1 publication Critical patent/CA2359486A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention concerne des polypeptides BASB052, des polynucléotides codant pour les polypeptides BASB052, et des techniques de production de ces polypeptides au moyen de techniques de recombinaison. L'invention concerne également leurs utilisations diagnostique, prophylactique et thérapeutique.
CA002359486A 1999-01-15 2000-01-10 Polypeptides basb052 de neisseria meningitidis Abandoned CA2359486A1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB9900841 1999-01-15
GB9900841.9 1999-01-15
GB9901946.5 1999-01-28
GBGB9901946.5A GB9901946D0 (en) 1999-01-28 1999-01-28 Novel compounds
PCT/EP2000/000136 WO2000042192A1 (fr) 1999-01-15 2000-01-10 POLYPEPTIDES BASB052 DE $i(NEISSERIA MENINGITIDIS)

Publications (1)

Publication Number Publication Date
CA2359486A1 true CA2359486A1 (fr) 2000-07-20

Family

ID=26314989

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002359486A Abandoned CA2359486A1 (fr) 1999-01-15 2000-01-10 Polypeptides basb052 de neisseria meningitidis

Country Status (6)

Country Link
EP (1) EP1144645A1 (fr)
JP (1) JP2004537954A (fr)
CN (1) CN1350585A (fr)
AU (1) AU2289000A (fr)
CA (1) CA2359486A1 (fr)
WO (1) WO2000042192A1 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2281956C2 (ru) 1999-10-29 2006-08-20 Чирон С.Р.Л. Антигенные пептиды neisseria
ES2281409T3 (es) 2000-02-28 2007-10-01 Novartis Vaccines And Diagnostics S.R.L. Expresion heterologa de proteinas de neisseria.
MX339524B (es) 2001-10-11 2016-05-30 Wyeth Corp Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
KR101594228B1 (ko) 2010-08-23 2016-02-15 와이어쓰 엘엘씨 네이세리아 메닌기티디스 ｒＬＰ２０８６ 항원의 안정한 제제
NZ607224A (en) 2010-09-10 2014-11-28 Wyeth Llc Non-lipidated variants of neisseria meningitidis orf2086 antigens
JP5957541B2 (ja) 2012-02-02 2016-07-27 ノバルティス アーゲー 髄膜炎菌における増加したタンパク質発現のためのプロモータ
MX359256B (es) 2012-03-09 2018-09-19 Pfizer Composiciones de neisseria meningitidis y metodos de las mismas.
SA115360586B1 (ar) 2012-03-09 2017-04-12 فايزر انك تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها
US9802987B2 (en) 2013-03-08 2017-10-31 Pfizer Inc. Immunogenic fusion polypeptides
RU2662968C2 (ru) 2013-09-08 2018-07-31 Пфайзер Инк. Иммуногенная композиция против neisseria meningitidis (варианты)
AU2016221318B2 (en) 2015-02-19 2020-06-25 Pfizer Inc. Neisseria meningitidis compositions and methods thereof
US11530394B2 (en) * 2016-03-15 2022-12-20 University Of Massachusetts Anti-CRISPR compounds and methods of use
AU2018215585B2 (en) 2017-01-31 2022-03-17 Pfizer Inc. Neisseria meningitidis compositions and methods thereof
EP4034157A1 (fr) 2019-09-27 2022-08-03 Pfizer Inc. Compositions de neisseria meningitidis et méthodes associées

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2751000B1 (fr) * 1996-07-12 1998-10-30 Inst Nat Sante Rech Med Adn specifiques des bacteries de l'espece neisseria meningitidis, leurs procedes d'obtention et leurs applications biologiques
EP2261352A3 (fr) * 1998-05-01 2012-01-04 Novartis Vaccines and Diagnostics, Inc. Antigènes de Neisseria meningitidis et compositions

Also Published As

Publication number Publication date
JP2004537954A (ja) 2004-12-24
CN1350585A (zh) 2002-05-22
AU2289000A (en) 2000-08-01
EP1144645A1 (fr) 2001-10-17
WO2000042192A1 (fr) 2000-07-20

Similar Documents

Publication Publication Date Title
US8217159B2 (en) BASB082 polynucleotides
CA2360084A1 (fr) Composes immunogeniques
CA2359486A1 (fr) Polypeptides basb052 de neisseria meningitidis
CA2360658A1 (fr) Polypeptides antigeniques de neisseria meningitidis, polynucleotides correspondants et anticorps protecteurs
US20100203057A1 (en) Novel compounds
US20080057067A1 (en) Polypeptides and Polynucleotides "BASB040" From Neisseria Meningitidis and Vaccine Comprising Said Polypeptides and Polynucleotides
US7521549B2 (en) Compounds
US20050075485A1 (en) Neisseria meningitidis antigen
WO2000043517A1 (fr) Polynucleotides et polypeptides basb055 de neisseria meningitis et leurs utilisations
WO2000042191A2 (fr) Nouveaux composes
CA2359799A1 (fr) Antigene contre le serogroupe b de neisseria meningitidis
CA2363565A1 (fr) Polypeptides basb059 provenant de neisseria meningitidis

Legal Events

Date Code Title Description
FZDE Dead